Catálogo de las macroalgas bénticas marinas de Argelia, parte II: Ulvophyceae

The seaweed diversity of the Mediterranean is still not completely known, especially in some areas of its African coasts. As an effort to complete a more detailed catalogue to fill such gap, an updated checklist of seaweeds from Algeria, based on updated literature records, is developed using as starting point the checklist of Perret-Boudouresque and Seridi published in 1989. In the present work, in which we include the Ulvophyceae Mattox & K.D.Stewart, we list 73 accepted taxa from this group, among which there are 8 new records for Algeria.The seaweed diversity of the Mediterranean is still not completely known, especially in some areas of its African coasts. As an effort to complete a more detailed catalogue to fill such gap, an updated checklist of seaweeds from Algeria, based on updated literature records, is developed using as starting point the checklist of Perret-Boudouresque and Seridi published in 1989. In the present work, in which we include the Ulvophyceae Mattox & K.D.Stewart, we list 73 accepted taxa from this group, among which there are 8 new records for Algeria

Checklist of the benthic marine macroalgae from Algeria, part II: Ulvophyceae

The seaweed diversity of the Mediterranean is still not completely known, especially in some areas of its African coasts. As an effort to complete a more detailed catalogue to fill such gap, an updated checklist of seaweeds from Algeria, based on updated literature records, is developed using as starting point the checklist of Perret-Boudouresque and Seridi published in 1989. In the present work, in which we include the Ulvophyceae Mattox & K.D.Stewart, we list 73 accepted taxa from this group, among which there are 8 new records for Algeria

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe